Spectrum Pharma Investors Sue Over Rejected FDA Advice
Officers and directors at Spectrum Pharmaceuticals Inc. were hit with a shareholder derivative action in Delaware federal court on Thursday alleging they harmed investors and the company with a new drug...To view the full article, register now.
Already a subscriber? Click here to view full article